Ignite Creation Date:
2024-05-06 @ 8:16 PM
Last Modification Date:
2024-10-26 @ 3:23 PM
Study NCT ID:
NCT06311045
Status:
RECRUITING
Last Update Posted:
2024-06-24
First Post:
2024-03-08
Brief Title:
Obstructive Sleep Apnea OSA and Sex-Specific Responses to N-acetylcysteine NAC
Sponsor:
NYU Langone Health
Organization:
NYU Langone Health
Study Overview
Official Title:
Basis of Sex-specific Therapeutic Responses to Obstructive Sleep Apnea OSA a Trial of N-acetylcysteine NAC in Obstructive Sleep Apnea OSA
Status:
RECRUITING
Status Verified Date:
2024-06
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
This is a randomized controlled trial RCT of 4 weeks of study supplement N-acetylcysteine NAC versus placebo in persons with significant obstructive sleep apnea OSA who are receiving positive airway pressure therapy PAP the standard of care therapy The purpose of the study is to determine if NAC is associated with sex-specific changes in overnight oxidative stress inflammation as well as endothelial dysfunction in persons with OSA
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
False
Is a FDA Regulated Device?:
False
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None